In our previous study, we used anti-IL-17 neutralizing antibody to inhibit IL-17 expression in BPD mice and found that lung inflammation in BPD was reduced after IL-17 intervention (13). The gene discussed is IL17A; the disease is bronchopulmonary dysplasia.